Surgepays is trading 10.01% down at $0.13 on October 12, 2026, with no clear company-specific announcement identified to explain the decline.
- The broader market was mixed, not sharply lower, and does not clearly account for the drop.
- The October 9 Nasdaq-listed 424B5 filing alone does not establish a cause.
- A September Nasdaq notice disclosed further time to regain minimum bid-price compliance, but it is not a confirmed catalyst for this session.